Free Trial

Amplifon (OTCMKTS:AMFPF) Sees Unusually-High Trading Volume - Still a Buy?

Amplifon logo with Medical background

Key Points

  • Amplifon S.p.A. shares experienced a significant increase in trading volume, reaching approximately 23,018 shares, which is a 781% increase from the prior session.
  • Morgan Stanley has reaffirmed an "overweight" rating on Amplifon, indicating a positive outlook for the company's stock.
  • The company's current market capitalization stands at $3.94 billion, with a PE ratio of 25.68, suggesting it is valued at approximately 25 times its earnings.
  • Looking to Export and Analyze Amplifon Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 23,018 shares changed hands during trading, an increase of 781% from the previous session's volume of 2,613 shares.The stock last traded at $17.46 and had previously closed at $17.25.

Analyst Ratings Changes

Separately, Morgan Stanley reaffirmed an "overweight" rating on shares of Amplifon in a research report on Wednesday, June 25th.

Check Out Our Latest Analysis on AMFPF

Amplifon Trading Up 1.2%

The firm has a market capitalization of $3.94 billion, a PE ratio of 25.68 and a beta of 0.53. The business has a 50 day moving average price of $22.98 and a 200-day moving average price of $23.11. The company has a current ratio of 0.62, a quick ratio of 0.54 and a debt-to-equity ratio of 0.85.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines